<!DOCTYPE html>
<html lang="en-us"
  dir="ltr">

<head>
  <meta charset="utf-8">
<meta name="viewport" content="width=device-width">



<link rel="icon" type="image/ico" href="https://reports.muthu.co/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://reports.muthu.co/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://reports.muthu.co/favicon-32x32.png">
<link rel="icon" type="image/png" sizes="192x192" href="https://reports.muthu.co/android-chrome-192x192.png">
<link rel="apple-touch-icon" sizes="180x180" href="https://reports.muthu.co/apple-touch-icon.png">

<meta name="description" content=""/>



<title>
    
    Gufic BioSciences Ltd - Feb 2025 Earnings Call Transcript Analysis | Financial Report Insights
    
</title>
<link href="/pagefind/pagefind-ui.css" rel="stylesheet">
<script src="/pagefind/pagefind-ui.js"></script>
<link rel="canonical" href="https://reports.muthu.co/posts/gufic-biosciences-ltd---feb-2025-earnings-call-transcript-analysis/"/>

<meta property="og:url" content="https://reports.muthu.co/posts/gufic-biosciences-ltd---feb-2025-earnings-call-transcript-analysis/">
  <meta property="og:site_name" content="Financial Report Insights">
  <meta property="og:title" content="Gufic BioSciences Ltd - Feb 2025 Earnings Call Transcript Analysis">
  <meta property="og:description" content="Earnings Call Transcript Analysis Report # Financial Performance # Key Financial Metrics (Q3 FY25 vs Q3 FY24) # Total Revenue from Operations: INR 207.8 crores (up from INR 201.8 crores). Quote (CFO): “The total revenue for the operation for the financial year ‘24- ‘25 in Q3 is INR 207.8 crores compared to Q3 of financial year ‘23- ‘24 of INR 201.8 crores.” EBITDA: INR 35.8 crores (down from INR 36.9 crores). EBITDA Margin: 17.23% (down from 18.29%). Profit Before Tax (PBT): INR 26.3 crores (down from INR 29.6 crores). PBT Margin: 12.66% (down from 14.67%). Profit After Tax (PAT): INR 19.4 crores (down from INR 22.3 crores). PAT Margin: 9.34% (down from 11.05%). Key Financial Metrics (9M FY25 vs 9M FY24) # Total Revenue from Operations: INR 614.8 crores (slightly down from INR 616.7 crores). EBITDA: INR 111.6 crores (slightly down from INR 112.9 crores). EBITDA Margin: 18.15% (slightly down from 18.31%). Profit Before Tax (PBT): INR 83.6 crores (down from INR 88.6 crores). PBT Margin: 13.60% (down from 14.37%). Profit After Tax (PAT): INR 61.9 crores (down from INR 66.1 crores). PAT Margin: 10.07% (down from 10.72%). Revised Guidance or Forecasts # Indore facility expected to generate INR 6 crores in Q3 FY25, with Q4 FY25 revenue projected at INR 20 crores (CFO) or 2-3x of Q3 (CEO). Indore facility FY26 revenue forecast: “minimum INR150 crores additional revenue” (CFO). Margin pressure expected in the near term due to Indore start-up costs, with improvement anticipated post-FY26. Quote (CFO): “after ‘26, when the capacity utilization of Indore will be picked up, I think that the EBITDA margin and PAT margin is going to improve after ‘26 onwards.” Areas of Growth or Decline # Revenue showed slight YoY growth for Q3 but was flat for 9M. EBITDA, PBT, and PAT declined both YoY for Q3 and for the 9M period, with corresponding margin compression. Download Transcript">
  <meta property="og:locale" content="en_us">
  <meta property="og:type" content="article">
    <meta property="article:section" content="posts">
    <meta property="article:published_time" content="2025-02-21T13:55:34+00:00">
    <meta property="article:modified_time" content="2025-02-21T13:55:34+00:00">
    <meta property="article:tag" content="Gufic Biosciences Ltd.">
    <meta property="article:tag" content="GUFICBIO">
    <meta property="article:tag" content="Branded Medicines">
    <meta property="article:tag" content="Healthcare">
    <meta property="article:tag" content="Small Cap">
    <meta property="article:tag" content="Earnings Call">













<link rel="stylesheet" href="/assets/combined.min.722a154090e948dfc0b4cf97263194700c53c73fc095c249b60a5c9caddbbf84.css" media="all">




      <script async src="https://www.googletagmanager.com/gtag/js?id=G-T7PH4WNH24"></script>
      <script>
        var doNotTrack = false;
        if ( false ) {
          var dnt = (navigator.doNotTrack || window.doNotTrack || navigator.msDoNotTrack);
          var doNotTrack = (dnt == "1" || dnt == "yes");
        }
        if (!doNotTrack) {
          window.dataLayer = window.dataLayer || [];
          function gtag(){dataLayer.push(arguments);}
          gtag('js', new Date());
          gtag('config', 'G-T7PH4WNH24');
        }
      </script>




<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-3609399560636561" crossorigin="anonymous"></script>
</head>







<body class="light">
  <div class="content">
    <header>
      

<div class="header">

    
    <div id="search"></div>
</div>

    </header>
    <main class="main">
      





<div class="breadcrumbs">
    
    <a href="/">Home</a>
    <span class="breadcrumbs-separator"> > </span>
    
    <a href="/posts/">Posts</a>
    <span class="breadcrumbs-separator"> > </span>
    
    <a class="breadcrumbs-current" href="/posts/gufic-biosciences-ltd---feb-2025-earnings-call-transcript-analysis/">Gufic BioSciences Ltd - Feb 2025 Earnings Call Transcript Analysis</a>
</div>



<div >

  <div class="single-intro-container">

    

    <h1 class="single-title" data-pagefind-body>Gufic BioSciences Ltd - Feb 2025 Earnings Call Transcript Analysis</h1>
    

    

    <p class="single-readtime">
      
      
      
      <time datetime="2025-02-21T13:55:34&#43;00:00">February 21, 2025</time>
      

      
      &nbsp; · &nbsp;
      2 min read
      
    </p>

  </div>

  

  
  

  <div class="single-tags">
    
    <span>
      <a href="https://reports.muthu.co/tags/gufic-biosciences-ltd./">#Gufic Biosciences Ltd.</a>
    </span>
    
    
    <span>
      <a href="https://reports.muthu.co/tags/guficbio/">#GUFICBIO</a>
    </span>
    
    
    <span>
      <a href="https://reports.muthu.co/tags/branded-medicines/">#Branded Medicines</a>
    </span>
    
    
    <span>
      <a href="https://reports.muthu.co/tags/healthcare/">#Healthcare</a>
    </span>
    
    
    <span>
      <a href="https://reports.muthu.co/tags/small-cap/">#Small Cap</a>
    </span>
    
    
    <span>
      <a href="https://reports.muthu.co/tags/earnings-call/">#Earnings Call</a>
    </span>
    
    
  </div>

  
  

  

  
  <aside class="toc">
    <p><strong>Table of contents</strong></p>
    <nav id="TableOfContents">
  <ul>
    <li><a href="#earnings-call-transcript-analysis-report">Earnings Call Transcript Analysis Report</a></li>
    <li><a href="#financial-performance">Financial Performance</a>
      <ul>
        <li><a href="#key-financial-metrics-q3-fy25-vs-q3-fy24">Key Financial Metrics (Q3 FY25 vs Q3 FY24)</a></li>
        <li><a href="#key-financial-metrics-9m-fy25-vs-9m-fy24">Key Financial Metrics (9M FY25 vs 9M FY24)</a></li>
        <li><a href="#revised-guidance-or-forecasts">Revised Guidance or Forecasts</a></li>
        <li><a href="#areas-of-growth-or-decline">Areas of Growth or Decline</a></li>
      </ul>
    </li>
  </ul>
</nav>
  </aside>
  

  

  <div class="single-content">
    <h2 class="heading" id="earnings-call-transcript-analysis-report">
  Earnings Call Transcript Analysis Report
  <a class="anchor" href="#earnings-call-transcript-analysis-report">#</a>
</h2>
<h2 class="heading" id="financial-performance">
  Financial Performance
  <a class="anchor" href="#financial-performance">#</a>
</h2>
<h3 class="heading" id="key-financial-metrics-q3-fy25-vs-q3-fy24">
  Key Financial Metrics (Q3 FY25 vs Q3 FY24)
  <a class="anchor" href="#key-financial-metrics-q3-fy25-vs-q3-fy24">#</a>
</h3>
<ul>
<li><strong>Total Revenue from Operations:</strong> INR 207.8 crores (up from INR 201.8 crores).
<ul>
<li>Quote (CFO): &ldquo;The total revenue for the operation for the financial year &lsquo;24- &lsquo;25 in Q3 is INR 207.8 crores compared to Q3 of financial year &lsquo;23- &lsquo;24 of INR 201.8 crores.&rdquo;</li>
</ul>
</li>
<li><strong>EBITDA:</strong> INR 35.8 crores (down from INR 36.9 crores).</li>
<li><strong>EBITDA Margin:</strong> 17.23% (down from 18.29%).</li>
<li><strong>Profit Before Tax (PBT):</strong> INR 26.3 crores (down from INR 29.6 crores).</li>
<li><strong>PBT Margin:</strong> 12.66% (down from 14.67%).</li>
<li><strong>Profit After Tax (PAT):</strong> INR 19.4 crores (down from INR 22.3 crores).</li>
<li><strong>PAT Margin:</strong> 9.34% (down from 11.05%).</li>
</ul>
<h3 class="heading" id="key-financial-metrics-9m-fy25-vs-9m-fy24">
  Key Financial Metrics (9M FY25 vs 9M FY24)
  <a class="anchor" href="#key-financial-metrics-9m-fy25-vs-9m-fy24">#</a>
</h3>
<ul>
<li><strong>Total Revenue from Operations:</strong> INR 614.8 crores (slightly down from INR 616.7 crores).</li>
<li><strong>EBITDA:</strong> INR 111.6 crores (slightly down from INR 112.9 crores).</li>
<li><strong>EBITDA Margin:</strong> 18.15% (slightly down from 18.31%).</li>
<li><strong>Profit Before Tax (PBT):</strong> INR 83.6 crores (down from INR 88.6 crores).</li>
<li><strong>PBT Margin:</strong> 13.60% (down from 14.37%).</li>
<li><strong>Profit After Tax (PAT):</strong> INR 61.9 crores (down from INR 66.1 crores).</li>
<li><strong>PAT Margin:</strong> 10.07% (down from 10.72%).</li>
</ul>
<h3 class="heading" id="revised-guidance-or-forecasts">
  Revised Guidance or Forecasts
  <a class="anchor" href="#revised-guidance-or-forecasts">#</a>
</h3>
<ul>
<li>Indore facility expected to generate INR 6 crores in Q3 FY25, with Q4 FY25 revenue projected at INR 20 crores (CFO) or 2-3x of Q3 (CEO).</li>
<li>Indore facility FY26 revenue forecast: &ldquo;minimum INR150 crores additional revenue&rdquo; (CFO).</li>
<li>Margin pressure expected in the near term due to Indore start-up costs, with improvement anticipated post-FY26.
<ul>
<li>Quote (CFO): &ldquo;after &lsquo;26, when the capacity utilization of Indore will be picked up, I think that the EBITDA margin and PAT margin is going to improve after &lsquo;26 onwards.&rdquo;</li>
</ul>
</li>
</ul>
<h3 class="heading" id="areas-of-growth-or-decline">
  Areas of Growth or Decline
  <a class="anchor" href="#areas-of-growth-or-decline">#</a>
</h3>
<ul>
<li>Revenue showed slight YoY growth for Q3 but was flat for 9M.</li>
<li>EBITDA, PBT, and PAT declined both YoY for Q3 and for the 9M period, with corresponding margin compression.</li>
</ul>



<div class="button-container">    
    <a href="http://gufic.com/Notice/Written%20Transcript%2017022025.pdf" target="_blank" class="report-button">
      <i class="fas fa-file-pdf"></i> Download Transcript
    </a>
</div>
    



    
  </div>

  


  

  
  

<div class="single-pagination">
    <hr />

    <div class="flex">

        <div class="single-pagination-prev">
            
            <div class="single-pagination-container-prev">
                <div class="single-pagination-text">←</div>
                <div class="single-pagination-text">
                    <a href="/posts/bajaj-consumer-care-ltd---feb-2025-earnings-call-transcript-analysis/">
                        Bajaj Consumer Care Ltd - Feb 2025 Earnings Call Transcript Analysis
                    </a>
                </div>
            </div>
            
        </div>

        <div class="single-pagination-next">
            
            <div class="single-pagination-container-next">
                <div class="single-pagination-text">
                    <a href="/posts/integrated-industries-limited2025-02-22/">
                        Integrated Industries Limited: Q3 FY25 Earnings Call Transcript Analysis
                    </a>
                </div>
                <div class="single-pagination-text">→</div>
            </div>
            
        </div>

    </div>

    <hr />
</div>



  <div id="disqus_thread"></div>
<script>
    

    

    (function() { 
    var d = document, s = d.createElement('script');
    s.src = 'https://muthuai.disqus.com/embed.js';
    s.setAttribute('data-timestamp', +new Date());
    (d.head || d.body).appendChild(s);
    })();
</script>
<noscript>Please enable JavaScript to view the <a href="https://disqus.com/?ref_noscript">comments powered by Disqus.</a></noscript>
  

  

  
  <div class="back-to-top">
    <a href="#top">
      back to top
    </a>
  </div>
  

</div>


    </main>
  </div>

  <footer>
    

    
    
    
    <p>Made with ♥ in India</p>
    


  </footer>

  

</body>

<script>

  function isAuto() {
    return document.body.classList.contains("auto");
  }

  function setTheme() {
    if (!isAuto()) {
      return
    }

    document.body.classList.remove("auto");
    let cls = "light";
    if (window.matchMedia && window.matchMedia('(prefers-color-scheme: dark)').matches) {
      cls = "dark";
    }

    document.body.classList.add(cls);
  }

  function invertBody() {
    document.body.classList.toggle("dark");
    document.body.classList.toggle("light");
  }

  if (isAuto()) {
    window.matchMedia('(prefers-color-scheme: dark)').addListener(invertBody);
  }

  setTheme();

</script>
<script>
    window.addEventListener('DOMContentLoaded', (event) => {
        new PagefindUI({ element: "#search", showSubResults: false, showImages: false });
    });
</script>
<script defer src="/js/copy-code.js"></script>
</html>